The emerging approach of the medication represents a significant advance in the management of the condition. Different to existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide466584.webbuzzfeed.com/42429176/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment